Renalytix: Stephen Brunton, Matthew Jay Budoff, Barry Freeman, and More
Renalytix said it has appointed an eight-member clinical advisory board that will help the company advance use of its blood-based KidneyIntelX.dkd test for diabetic kidney disease. The US Food and Drug Administration granted Renalytix de novo marketing authorization for its KidneyIntelX testing platform in June. Stephen Brunton is executive director of the Primary Care Metabolic Group and Editor-in-Chief of Clinical Diabetes. Matthew Jay Budoff is a professor of medicine at the David Geffen School of Medicine at the University of California-Los Angeles and endowed chair of preventive cardiology at the Harbor-UCLA Medical Center. Barry Freedman is chief of the nephrology section at the Wake Forest University School of Medicine. Ralph DeFronzo is a professor of medicine and chief of the diabetes division at the University of Texas Health Science Center as well as the deputy director of the Texas Diabetes Institute. Holly Mattix-Kramer is a professor in the division of nephrology and hypertension at Loyola University Chicago, associate director of research for the Medicine Service Line, and founding director of the Hines VA Serwa Research Center on Aging. Javier Morales is vice president and principal clinical trials investigator at the Advanced Internal Medicine Group. Joseph Vassalotti is chief medical officer of the National Kidney Foundation and a clinical professor of medicine at the Mount Sinai Icahn School of Medicine. And Eugene Wright is a consulting associate for the Duke University Medical Center and medical director for performance improvement at the Charlotte Area Health Education Center.